Alpha Fusion

Alpha Fusion is a biotech company in Osaka, Japan. It has raised $9.2M across 1 round, most recently a $9.2M Series B in August 2023.

Unlock the potential of alpha-particle therapy for human health.

Headquarters
Osaka
Employees
11–50
Business Model
B2B
Total Funding
$9.2M
Last Round
$9.2M Series BAug 2023
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round for this company. The full record is or through the API.

About

Alpha Fusion Inc. is a Japan-based clinical-stage biotech company commercializing Targeted Alpha Therapy (TAT) based on astatine-211 (211At). The company integrates expertise in radiochemistry, drug discovery, and clinical medicine to develop innovative radiopharmaceuticals that destroy cancer cells with precision while minimizing damage to surrounding healthy tissue. Alpha Fusion has multiple pipelines leveraging astatine-211, with two programs currently in clinical trials and company-sponsored trials planned from 2026. The company collaborates with Osaka University, Mitsubishi Tanabe Pharma, and Veneno Technologies.

Summary

It lists 11–50 employees. It has raised $9.2M in total across 1 round, most recently a $9.2M Series B round in Aug 2023.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BAug 2023
$9.2M

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alpha Fusion on Indexed.vc
<a href="https://indexed.vc/companies/alpha-fusion"><img src="https://indexed.vc/api/badge/company/alpha-fusion" alt="Alpha Fusion on Indexed.vc" width="260" height="76" /></a>